Merck KGaA said it’s in advanced talks to purchase SpringWorks Therapeutics Inc., sending shares of the US cancer and rare diseases drugmaker soaring. One of SpringWorks’ drugs, Ogsiveo ...

The offseason is over and spring training has arrived. Pitchers and catchers will report to spring camps across Arizona and ...

NEW YORK/FRANKFURT (Reuters) – Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases drugmaker Springworks Therapeutics ...

09:50 EST Merck KGaA (MKGAY) in talks to buy SpringWorks Therapeutics (SWTX), Reuters reports Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing ...

If you hate coastal superpowers, this was a bad offseason for you. The Dodgers talked to Juan Soto and didn’t sign him, but then went about securing just about every other desirable star in the ...

Merck KGaA (MKGAY), the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases drugmaker SpringWorks Therapeutics (SWTX), Reuters’ Sabrina Valle ...

The exact terms of a potential deal weren't known. Germany's Merck confirmed that it's in talks with SpringWorks (NASDAQ:SWTX) on a potential deal, according to a statement on Monday. There is no ...

SURPRISE, Ariz. - There certainly was less buzz to the Rangers’ first day of spring training Wednesday than a year ago when ...

SpringWorks Therapeutics (NASDAQ:SWTX) soared 12% after a report that Merck KGaA (OTCPK:MKGAF) is in advanced discussions to acquire the cancer and rare disease drugmaker. If an agreement is ...

Germany's Merck KGaA is in advanced talks to buy U.S. cancer and rare diseases biotech company Springworks Therapeutics, Reuters says, citing unnamed sources. -- The deal could be finalized in the ...

NEW YORK/FRANKFURT (Reuters) - Merck KGaA, the German healthcare and technology group, said on Monday it is in advanced talks to acquire U.S. cancer and rare diseases drugmaker SpringWorks ...